Does TRIMETAZIDINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with TRIMETAZIDINE. This represents 1.4% of all adverse event reports for TRIMETAZIDINE.
6
Reports of Malignant neoplasm progression with TRIMETAZIDINE
1.4%
of all TRIMETAZIDINE reports
3
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TRIMETAZIDINE?
Of the 6 reports, 3 (50.0%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIMETAZIDINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TRIMETAZIDINE Cause?
Cardiac failure (73)
Rales (63)
Ejection fraction decreased (62)
Dyspnoea (59)
Fatigue (59)
Diastolic dysfunction (52)
Oedema peripheral (49)
Tricuspid valve incompetence (49)
Mitral valve incompetence (45)
Dyspnoea at rest (44)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TRIMETAZIDINE Alternatives Have Lower Malignant neoplasm progression Risk?
TRIMETAZIDINE vs TRIMETHOBENZAMIDE
TRIMETAZIDINE vs TRIMETHOPRIM
TRIMETAZIDINE vs TRIMIPRAMINE
TRIMETAZIDINE vs TRIPROLIDINE
TRIMETAZIDINE vs TRIPTORELIN